Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated
<p>Abstract</p> <p>Purpose</p> <p>Inhibitors of epidermal growth factor receptor (EGFR) have shown dramatic results in a subset of patients with non-small cell lung cancer (NSCLC), and have also been shown to enhance the effect of ionizing radiation (IR). We investigate...
Main Authors: | Park Soo-Yeon, Kim Young, Pyo Hongryull |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-08-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/222 |
Similar Items
-
The assessment of radiosensitivity in patients with ataxia-telangiectasia syndrome and in carriers of the mutated ATM gene using lymphoblastoid cell lines
by: Barbara Pietrucha, et al.
Published: (2018-10-01) -
Effect and Mechanism of Gefitinib Inhibition on Non-small Cell Lung Cancer
Radiosensitivity of HCC827 and H358 Cell Lines
by: Ziye GAO, et al.
Published: (2012-06-01) -
Ataxia telangiectasia : mutation detection in ataxia telangiectasia families and early-onset breast cancer cases
by: Izatt, Louise Patricia
Published: (2000) -
MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
by: Michal Smida, et al.
Published: (2016-12-01) -
Individual Radiosensitivity Assessment of the Families of Ataxia-Telangiectasia Patients by G2-Checkpoint Abrogation
by: Asghar Aghamohammadi, et al.
Published: (2019-03-01)